Report of Foreign Issuer (6-k)
30 December 2015 - 9:01AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
Form 6-K
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of December 2015
Commission File Number: 001-33036
Mindray
Medical International Limited
Mindray Building, Keji 12th Road South,
Hi-tech Industrial Park, Nanshan,
Shenzhen 518057
Peoples Republic of China
(Address of principal executive office)
Indicate by check mark whether
the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F þ Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T
Rule 101(b)(7): ¨
Indicate by check mark whether by furnishing the
information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨
No þ
If Yes is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2(b): N/A
Mindray Medical International Limited (“Mindray”)
today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 28,
2015
At the meeting, Mindray shareholders voted to re-elect incumbent
director, chairman of board Xu Hang and director Ronald Ede, each to serve a three-year term.
In addition, Mindray shareholders ratified the appointment of
PricewaterhouseCoopers as the Company’s independent registered public accounting firm for the fiscal year ending December 31,
2015.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
Mindray Medical International Limited |
|
|
By: |
|
/s/ Alex Lung |
|
|
Name: |
|
Alex Lung |
|
|
Title: |
|
Chief Financial Officer |
Date: December 29, 2015
Montage Resources (NYSE:MR)
Historical Stock Chart
From Apr 2024 to May 2024
Montage Resources (NYSE:MR)
Historical Stock Chart
From May 2023 to May 2024